The Patent Finder

Apt Therapeutics, Inc.

Also on record
Records under this name other than the patents Apt Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 3 of 3 · Back to Apt Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 8,021,866Therapeutic Use of Adpase Enhanced Apyrases
Term ended
Term ended Sep 7, 2026 · High confidence
Term endedTerm ended Sep 7, 2026High confidence
US 7,390,485Design and Therapeutic Use of Adpase Enhanced Apyrases
Term ended
Term ended Jul 7, 2026 · High confidence
Term endedTerm ended Jul 7, 2026High confidence
US 7,247,300Therapeutic Use of Soluble CD39L3
Term ended
Term ended Apr 21, 2025 · High confidence
Term endedTerm ended Apr 21, 2025High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited